Bausch Health Companies Inc (BHC)

9.86
+0.28(+2.92%)
After Hours
9.81
-0.05(-0.51%)
- Real-time Data
  • Volume:
    9,763,923
  • Day's Range:
    9.29 - 9.93
  • 52 wk Range:
    7.80 - 32.54

BHC Overview

Prev. Close
9.58
Day's Range
9.29-9.93
Revenue
8.33B
Open
9.48
52 wk Range
7.8-32.54
EPS
-1.14
Volume
9,763,923
Market Cap
3.55B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
6,221,906
P/E Ratio
-
Beta
1.77
1-Year Change
-69.15%
Shares Outstanding
361,479,708
Next Earnings Date
Aug 09, 2022
What is your sentiment on Bausch Health?
or
Market is currently closed. Voting is open during market hours.

Bausch Health Companies Inc News

Bausch Health Companies Inc Analysis

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
19600

Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
  • bullish
    0
    • will look at this again at around $25, bearish till then
      0
      • sorry...who wrote the next comment.
        1
        • sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
          0
          • I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
            4
            • Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
              0
              • Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
                0
              • Jeremiah Cox . re: "have a feeling", never be emotional about the markets.......it'd hurt you
                0